We have the tools
to drive your commercial success
We firmly believe technology is the backbone of any organization—with all the regulations facing biotech and pharma, it is especially critical for your organization to implement the right solutions, at the right times, to drive product quality and inspection readiness, ensure GxP compliance, and ultimately, maximize patient access and commercial revenue.
How We Help
We identify the technologies your organization needs to scale from IND submission to NDA approval and all the way to commercial launch. We manage implementation of the commercial systems needed to support field teams, optimize HCP engagement, enhance patient experience, and drive commercial revenue. We help scale your quality processes and systems to prepare you for commercial-level manufacturing. We advise on the right AI and ML investments for your organization and help drive effective and ethical end user adoption. No matter how innovative and impactful your therapies are, your commercial success will fall short if you don’t have the right data, systems, and IT infrastructure in place. We have the tools to drive your commercial success.
IT Strategy
We’ll assess your existing technology landscape and will help you design a future state IT ecosystem that supports commercial volume, is built to scale, and strategically and intelligently leverages AI capabilities
Implementation Planning
We’ll help you select the specific technology platforms and vendors based on your needs—from there, we’ll conduct high-level implementation planning and will set up holistic portfolio governance to oversee implementation quality and shepherd cross-functional change
Program Management
We’ll lead each implementation to closure, driving delivery of high-quality solutions that meet all requirements and facilitating end user training and adoption
In Pharma and Biotech, over half of commercial product launches fail to meet performance targets
Despite groundbreaking science and significant investment, more than half of biotech launches underperform against expectations. The causes are rarely scientific. Instead, they’re operational: poor cross-functional alignment, unclear go-to-market strategies, and a lack of scalable infrastructure. To avoid these issues altogether, we work with pharmas and biotechs to drive commercial readiness well in advance of their PDUFA date, designing and implementing a scalable, compliant technology ecosystem that facilitates an effective launch, drives commercial revenue and enables positive patient outcomes.
%
of drug launches fail to meet pre-launch expectations
%+
of drugs fail to reach $250M in U.S.-based sales
%+